Market cap
$16 Mln
Revenue (TTM)
$20 Mln
P/E Ratio
--
P/B Ratio
2.4
Div. Yield
0 %
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
Market cap ($ Mln) |
16 | 6,044 |
Revenue ($ Mln) |
20 | 2,464 |
Net Profit ($ Mln) |
-3.00 | -61.20 |
Net Margin (%) |
-14.78 | -2.48 |
RoE (%) |
-51.08 | -2.17 |
Price to Earnings |
-- | -- |
Price-To-Book |
2.40 | 2.15 |
Income Statement ($ Mln)
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
|
Operating Revenue
|
20.26 | 2,463.70 |
|
Cost of Revenue
|
12.49 | 1,991.60 |
|
Gross Profit
|
8.41 | 484.50 |
|
Operating Expenses
|
10.70 | 273.20 |
|
Operating Profit (EBIT)
|
-2.93 | 136.30 |
|
Other Income
|
0.00 | 0.00 |
|
Profit before Tax
|
-2.95 | -57.70 |
|
Provision for Tax
|
0.04 | 3.50 |
|
Profit after Tax (Net Income)
|
-3.00 | -61.20 |
|
Minority Interest
|
0.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 0.00 |
Liabilities ($ Mln)
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
|
Shareholder's Funds
|
5.45 | 2,811.10 |
|
Minority Interest
|
0.00 | 0.00 |
|
Non-Current Liabilities
|
0.60 | 2,508.60 |
|
Current Liabilities
|
3.79 | 429.60 |
|
Total Liabilities
|
12.33 | 4,960.20 |
Assets ($ Mln)
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
|
Non-Current Assets
|
3.79 | 4,980.40 |
|
Current Assets
|
6.05 | 768.90 |
|
Total Assets
|
12.33 | 4,960.20 |
|
Total Debt*
|
1.58 | 2,314.40 |
|
Net Current Assets
|
2.25 | 339.30 |
Cashflow ($ Mln)
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
|
Cash From Operating Activities
|
-1.48 | 340.10 |
|
Cash Flow from Investing Activities
|
-- | -- |
|
Cash from Financing Activities
|
-1.15 | -173.90 |
|
Net Cash Inflow / Outflow
|
-- | -- |
Ratios
Profitability Ratios
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
|
ROCE (%)
|
-35.63 | 0.07 |
|
ROE (%)
|
-51.08 | -2.17 |
|
ROA (%)
|
-18.09 | -1.06 |
|
EBIT Margin (%)
|
-11.50 | 0.91 |
|
Net Margin (%)
|
-14.78 | -2.48 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 |
Growth Ratios
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
|
Revenue Growth (%)
|
-11.16 | 11.38 |
|
EBIT Growth (%)
|
49.00 | -70.53 |
|
Net Profit Growth (%)
|
23.15 | -73.86 |
|
EPS Growth (%)
|
24.31 | -71.64 |
|
Book Value Growth (%)
|
-28.42 | 10.06 |
Valuation Ratios
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
|
Price / Earnings
|
-4.14 | 1,446.17 |
|
Price / Book Value
|
2.58 | 1.73 |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
-69.80 | 14.44 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
|
Debt to Equity
|
0.00 | 0.76 |
|
Short term debt to equity ratio
|
0.18 | 0.04 |
|
Current Ratio
|
1.59 | 1.79 |
|
Quick Ratio
|
1.59 | 1.79 |
|
Interest Coverage
|
-172.65 | 0.64 |
Operating Efficiency Ratios
| Psychemedics (PMD) | R1 RCM (RCM) | |
|---|---|---|
|
Debtors to sales (%)
|
16.41 | 18.54 |
|
Asset Turnover
|
1.22 | 0.43 |
|
Receivable days
|
64.32 | 58.62 |
|
Inventory Days
|
0.00 | 0.00 |
|
Payable days
|
16.01 | 5.79 |
|
Cash Conversion Cycle
|
48.31 | 52.83 |